4//SEC Filing
Morris Gabriel S 4
Accession 0001493152-24-020776
CIK 0001873835other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:25 PM ET
Size
9.0 KB
Accession
0001493152-24-020776
Insider Transaction Report
Form 4
Morris Gabriel S
DirectorCFO
Transactions
- Award
Common Stock
2024-05-20+194,218→ 280,034 total - Award
Common Stock
2024-05-20+24,141→ 270,844 total(indirect: See footnote) - Award
Common Stock
2024-05-20+24,141→ 24,141 total(indirect: See footnote)
Footnotes (3)
- [F1]Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity.
- [F2]Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
- [F3]Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.
Documents
Issuer
Immix Biopharma, Inc.
CIK 0001873835
Entity typeother
Related Parties
1- filerCIK 0001889967
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 5:25 PM ET
- Size
- 9.0 KB